Studio Dragon Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Studio Dragon heeft een totaal eigen vermogen van ₩710.1B en een totale schuld van ₩1.5B, wat de schuld-eigenvermogensverhouding op 0.2% brengt. De totale activa en totale passiva bedragen respectievelijk ₩902.1B en ₩192.0B. De EBIT Studio Dragon is ₩27.1B waardoor de rentedekking -16.9 is. Het heeft contanten en kortetermijnbeleggingen van ₩134.8B.

Belangrijke informatie

0.2%

Verhouding schuld/eigen vermogen

₩1.50b

Schuld

Rente dekkingsratio	-16.9x
Contant	₩134.80b
Aandelen	₩710.10b
Totaal verplichtingen	₩192.00b
Totaal activa	₩902.10b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Studio Dragon's (KOSDAQ:253450) Conservative Accounting Might Explain Soft Earnings

Mar 25

Some Investors May Be Worried About Studio Dragon's (KOSDAQ:253450) Returns On Capital

Mar 25

Does Studio Dragon's (KOSDAQ:253450) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 21

Is Studio Dragon Corporation's (KOSDAQ:253450) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 12

Studio Dragon Corporation's (KOSDAQ:253450) Popularity With Investors Is Clear

Dec 16

Can You Imagine How Studio Dragon's (KOSDAQ:253450) Shareholders Feel About The 24% Share Price Increase?

Nov 25

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₩334.9B ) A253450 } overtreffen de korte termijn passiva ( ₩175.4B ).

Langlopende schulden: De kortetermijnactiva A253450 ( ₩334.9B ) overtreffen de langetermijnschulden ( ₩16.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A253450 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van A253450 is de afgelopen 5 jaar gestegen van 0% naar 0.2%.

Schuldendekking: De schuld van A253450 wordt goed gedekt door de operationele kasstroom ( 9749.3% ).

Rentedekking: A253450 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Studio Dragon Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Third quarter 2024 earnings released: ₩203 loss per share (vs ₩605 profit in 3Q 2023)

Consensus revenue estimates decrease by 16%

The Price Is Right For Studio Dragon Corporation (KOSDAQ:253450)

Studio Dragon Corporation to Report Q3, 2024 Results on Nov 07, 2024

Second quarter 2024 earnings released: EPS: ₩273 (vs ₩339 in 2Q 2023)

Studio Dragon Corporation's (KOSDAQ:253450) Price In Tune With Earnings

Studio Dragon Corporation to Report Q2, 2024 Results on Aug 08, 2024

Studio Dragon (KOSDAQ:253450) May Have Issues Allocating Its Capital

Now 20% undervalued after recent price drop

Studio Dragon Corporation to Report Q1, 2024 Results on May 09, 2024

Studio Dragon's (KOSDAQ:253450) Conservative Accounting Might Explain Soft Earnings

Full year 2023 earnings released: EPS: ₩1,001 (vs ₩1,684 in FY 2022)

Studio Dragon Corporation, Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: ₩1,001 (vs ₩1,684 in FY 2022)

Consensus EPS estimates fall by 12%

Studio Dragon Corporation to Report Q4, 2023 Results on Feb 07, 2024

Third quarter 2023 earnings released

Investor sentiment improves as stock rises 15%

Studio Dragon Corporation to Report Q3, 2023 Results on Nov 08, 2023

New minor risk - Profit margin trend

Consensus EPS estimates fall by 11%

Studio Dragon Corporation to Report Q2, 2023 Results on Aug 10, 2023

Price target decreased by 7.4% to ₩80,722

Studio Dragon Corporation Announces Resignation of Kim Young-Kyu as Co-CEO

Consensus EPS estimates fall by 15%

Now 20% undervalued after recent price drop

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: ₩1,686 (vs ₩1,301 in FY 2021)

Studio Dragon Corporation to Report Q4, 2022 Results on Feb 09, 2023

Investor sentiment improved over the past week

Less than half of directors are independent

Studio Dragon Corporation announced that it expects to receive KRW 2.9999901 billion in funding

Studio Dragon Corporation to Report Q3, 2022 Results on Nov 08, 2022

Studio Dragon Corporation to Report Q2, 2022 Results on Aug 04, 2022

Studio Dragon Corporation to Report Q1, 2022 Results on May 11, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Studio Dragon Corporation to Report Q4, 2021 Results on Feb 10, 2022

Some Investors May Be Worried About Studio Dragon's (KOSDAQ:253450) Returns On Capital

Full year 2020 earnings released: EPS ₩1,044 (vs ₩941 in FY 2019)

Does Studio Dragon's (KOSDAQ:253450) Statutory Profit Adequately Reflect Its Underlying Profit?

Studio Dragon Corporation to Report Q4, 2020 Results on Feb 04, 2021

Is Studio Dragon Corporation's (KOSDAQ:253450) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

New 90-day high: ₩103,700

New 90-day high: ₩88,100

Studio Dragon Corporation's (KOSDAQ:253450) Popularity With Investors Is Clear

Can You Imagine How Studio Dragon's (KOSDAQ:253450) Shareholders Feel About The 24% Share Price Increase?

Studio Dragon Corporation announced that it expects to receive KRW 149.9998655 billion in funding from NAVER Corporation

New 90-day low: ₩78,100

Studio Dragon Corporation to Report Q3, 2020 Results on Nov 05, 2020

Studio Dragon Corporation to Report Q2, 2020 Results on Aug 06, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven